Results 1-10 of 13 returned containing "adynovate"
Results 1-10 of 13 returned containing "adynovate"
Prophylaxis Data - ADYNOVATE®
... Indications and Limitation of Use: ADYNOVATE® [Antihemophilic factor (Recombinant), PEGylated] is a human antihemophilic factor indicated for use in children and adults ...
Clinical Experience - ADYNOVATE®
... Indications and Limitation of Use: ADYNOVATE® [Antihemophilic factor (Recombinant), PEGylated] is a human antihemophilic factor indicated for use in children and adults ...
ADYNOVATE® Access and Resources - Official HCP Information
... Help your patients get started on ADYNOVATE Takeda is proud to offer a variety of programs and resources to help assist your patients with hemophilia A. This page ...
How Does ADYNOVATE® Work?
... ADYNOVATE: Striving to meet the treatment needs of hemophilia A patients ADYNOVATE is a full-length recombinant FVIII protein with an extended terminal half-life.1 ADYNOVATE is built on the ...
On-Demand Treatment with ADYNOVATE®
... Indications and Limitation of Use: ADYNOVATE® [Antihemophilic factor (Recombinant), PEGylated] is a human antihemophilic factor indicated for use in children and adults ...
ADYNOVATE® - Official Healthcare Professionals Site
... ADYNOVATE®, your hemophilia A patient can keep building on the foundation you've helped them establish with the TAKEDA FVIII family. Because There's More to Their Stories Get ...
Safety Profile - ADYNOVATE®
... Indications and Limitation of Use: ADYNOVATE® [Antihemophilic factor (Recombinant), PEGylated] is a human antihemophilic factor indicated for use in children and adults ...
Patient Resources and Product Support - ADYNOVATE®
... ™ Free trial program Your patients may be eligible to receive 8 free-trial doses of ADYNOVATE with the FREEDOM OF CHOICE program. The free trial program is for new ...
Dosing - ADYNOVATE®
... days every week Treatment that can be personalized to work with your patients' needs1 ADYNOVATE has a twice-weekly prophylactic dosing schedule given on the same 2 days every week.1 ...
Perioperative Data - ADYNOVATE®
... Indications and Limitation of Use: ADYNOVATE® [Antihemophilic factor (Recombinant), PEGylated] is a human antihemophilic factor indicated for use in children and adults ...
You are being directed to ADYNOVATEPro.com. The information
on this website is intended for U.S. healthcare professionals only.